Abstract
Many approaches have been applied in biological and clinical studies aimed at simultaneously monitoring the expression of a large number of genes and at identifying the gene expression patterns associated with specific cell types. In the last decade, microarrays are emerged as an innovative tool to detect differentially expressed genes as disease-specific markers and to cluster the co-expressed genes regulating the molecular interactions. In fact, microarrays have been widely used for tumour diagnosis and classification, prediction of prognoses and treatment, pharmaceutical safety assessment, and understanding of molecular mechanisms, biochemical pathways, and gene networks. Besides the clinical relevance and the wide application of this technology, several problems remain to be addressed. This review illustrates the current and future directions of the microarray platform, and highlights the successes and strengths, as well as the shortcomings and limitations of this technology. An overview of microarray impact on the ocular and craniofacial diseases is provided.
Keywords: Craniofacial diseases, Gene expression, Microarray analysis, Ocular diseases
Current Pharmaceutical Analysis
Title: Microarrays as a Tool for Gene Expression Profiling: Application in Ocular and Craniofacial Research
Volume: 3 Issue: 3
Author(s): Maria Visalli, Mario Venza, Isabella Venza, Claudia Torino and Diana Teti
Affiliation:
Keywords: Craniofacial diseases, Gene expression, Microarray analysis, Ocular diseases
Abstract: Many approaches have been applied in biological and clinical studies aimed at simultaneously monitoring the expression of a large number of genes and at identifying the gene expression patterns associated with specific cell types. In the last decade, microarrays are emerged as an innovative tool to detect differentially expressed genes as disease-specific markers and to cluster the co-expressed genes regulating the molecular interactions. In fact, microarrays have been widely used for tumour diagnosis and classification, prediction of prognoses and treatment, pharmaceutical safety assessment, and understanding of molecular mechanisms, biochemical pathways, and gene networks. Besides the clinical relevance and the wide application of this technology, several problems remain to be addressed. This review illustrates the current and future directions of the microarray platform, and highlights the successes and strengths, as well as the shortcomings and limitations of this technology. An overview of microarray impact on the ocular and craniofacial diseases is provided.
Export Options
About this article
Cite this article as:
Maria Visalli , Mario Venza , Isabella Venza , Claudia Torino and Diana Teti , Microarrays as a Tool for Gene Expression Profiling: Application in Ocular and Craniofacial Research, Current Pharmaceutical Analysis 2007; 3 (3) . https://dx.doi.org/10.2174/157341207781369312
DOI https://dx.doi.org/10.2174/157341207781369312 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations
Current Pharmaceutical Design Overview of Tumor-Associated Antigens (TAAs) as Potential Therapeutic Targets for Prostate Cancer Therapy
Current Cancer Therapy Reviews Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress
Current Proteomics Targeting p73 - a Potential Approach in Cancer Treatment
Current Pharmaceutical Design Humoral Immunity in HIV-1 Exposure: Cause or Effect of HIV Resistance?
Current HIV Research Atomic Force Microscopy: The Characterisation of Amyloid Protein Structure in Pathology
Current Topics in Medicinal Chemistry Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Improving Safety of Gene Therapy
Current Drug Safety P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Current Cancer Drug Targets Recent Advances in Biological Strategies for Targeted Drug Delivery
Cardiovascular & Hematological Disorders-Drug Targets Phytochemicals, Medicinal and Food Applications of Shatavari (Asparagus racemosus): An Updated Review
The Natural Products Journal Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimers Disease
Current Alzheimer Research Specificity of Binding in Protein Kinases
Current Enzyme Inhibition Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Current Drug Targets <i>In Vitro</i> Anti-proliferative Properties of Flavonoids Isolated from <i>Artocarpus Heterophyllus</i> on Cancer Cell Lines
The Natural Products Journal Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets Therapeutic Antibodies
Current Molecular Medicine